Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15836663 | 0.88 | ALDH1A1 (0.79) | LMNAKMT2AMAPTGAAALDH1A1 | |
| SCHEMBL18181909 | 0.85 | NPC1 (0.70) | LMNAKMT2AMEN1MAPTGAA | |
| SCHEMBL18177838 | 0.82 | AKR1C3 (0.66) | LMNAAKR1C3KMT2AMEN1MAPT | |
| SCHEMBL16615491 | 0.81 | LMNA (0.64) | LMNAKMT2AMEN1MAPTGAA | |
| SCHEMBL17073208 | 0.78 | ATM (0.77) | LMNAKMT2AMEN1MAPTGAA | |
| SCHEMBL15836683 | 0.77 | ALDH1A1 (0.80) | LMNAKMT2AMEN1MAPTGAA | |
| SCHEMBL16921369 | 0.76 | KMT2A (0.79) | LMNAKMT2AMEN1MAPTNPSR1 | |
| SCHEMBL11951679 | 0.76 | MCOLN3 (1.00) | LMNAAKR1C3KMT2AMEN1MCOLN3 | |
| SCHEMBL15503757 | 0.75 | MEN1 (1.00) | LMNAAKR1C3KMT2AMEN1USP2 | |
| SCHEMBL31195230 | 0.75 | ALDH1A1 (0.64) | LMNAKMT2AMEN1MAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | NUTECH VENTURES (US) | 2019-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351883-B2 | Compounds for increasing lipid synthesis and storage | FASN, LIPC, SREBF2 | LMNA 966/4885AKR1C3 1041/4885KMT2A 2512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.